Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02795520
Title Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoTherapy Science, Inc.
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

myelodysplastic/myeloproliferative neoplasm

chronic myeloid leukemia

myelodysplastic syndrome

myeloproliferative neoplasm

Therapies

OTS167

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60637 United States Details
Weill Cornell Medicine New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field